| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/21/2002 | WO2001076529A3 Fertility associated antigen and methods of use thereof |
| 02/21/2002 | WO2001075031A3 Novel polypeptide - a human gonadotropin-releasing hormone 12 andpolynucleotide encoding it |
| 02/21/2002 | WO2001075006A3 A novel poypeptide, light chain of protein lattice 37 and the polynucleotide encoding the polypeptide |
| 02/21/2002 | WO2001074295A3 Phospholipid scramblases and methods of use thereof |
| 02/21/2002 | WO2001070807A3 G-protein associated molecules |
| 02/21/2002 | WO2001068849A8 Human ion channels |
| 02/21/2002 | WO2001068846A3 Transcription activator of the cited family |
| 02/21/2002 | WO2001068802A3 Genes of il-12p40 subunit mutated for improving the activity of il-12 and use thereof for dna vaccine adjuvant |
| 02/21/2002 | WO2001066747A8 Proteins named fctrx and nucleic acids encoding same |
| 02/21/2002 | WO2001066597A3 Inflammation-related gene |
| 02/21/2002 | WO2001064860A3 Recombinant influenza a viruses |
| 02/21/2002 | WO2001064240A3 Methods for promoting production of myelin by schwann cells |
| 02/21/2002 | WO2001060856A3 Vmglom gene and its mutations causing disorders with a vascular component |
| 02/21/2002 | WO2001060839A3 Method for refolding recombinant endostatin |
| 02/21/2002 | WO2001059116A3 19459 protein, a human g-protein coupled seven transmembrane receptor |
| 02/21/2002 | WO2001059110A3 34p3d7: a tissue specific protein highly expressed in prostate cancer |
| 02/21/2002 | WO2001058953A3 Identification of a domain in the tumor necrosis factor receptor family that mediates pre-ligand receptor assembly and function |
| 02/21/2002 | WO2001058484A3 Novel uses of mammalian ccr8 receptors and related reagents |
| 02/21/2002 | WO2001057213A3 Human bcl-x-like proteins and polynucleotides encoding the same |
| 02/21/2002 | WO2001057082A3 Extraction of growth factors from tissue |
| 02/21/2002 | WO2001055391A3 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer |
| 02/21/2002 | WO2001055319A3 Endocrine related nucleic acids, proteins and antibodies |
| 02/21/2002 | WO2001053475A3 Isolation and characterization of a n. crassa silencing gene and uses thereof |
| 02/21/2002 | WO2001053340A3 Transgenic mouse model of human neurodegenerative disease |
| 02/21/2002 | WO2001053338A3 Cbp86, a sperm specific protein |
| 02/21/2002 | WO2001052789A3 PAX8-PPARη NUCLEIC ACID MOLECULES AND POLYPEPTIDES AND USES THEREOF |
| 02/21/2002 | WO2001049832A3 Transduction of recombinases for inducible gene targeting |
| 02/21/2002 | WO2001046698A3 Tethered ligands and methods of use |
| 02/21/2002 | WO2001046232A3 Soluble interleukin-20 receptor |
| 02/21/2002 | WO2001044283A3 Human ion channels |
| 02/21/2002 | WO2001044282A3 Bcl-g polypeptides, encoding nucleic acids and methods of use |
| 02/21/2002 | WO2001043695A3 Peptide constructs for treating autoimmune and related diseases |
| 02/21/2002 | WO2001043693A3 Polynucleotide vaccines expressing codon optimized hiv-1 nef and modified hiv-1 nef |
| 02/21/2002 | WO2001042277A3 Complementary peptide ligands generated from the human genome |
| 02/21/2002 | WO2001039722A3 B7-h1, a novel immunoregulatory molecule |
| 02/21/2002 | WO2001037654A3 METHOD OF EXPRESSING dsRNA IN PLANTS TO INHIBIT INSECT PESTS |
| 02/21/2002 | WO2001032871A3 Follistatin-related protein zfsta4 |
| 02/21/2002 | WO2001031005A3 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 02/21/2002 | WO2001030300A3 Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies |
| 02/21/2002 | WO2001027278A3 A member of the immunoglobulin superfamily and uses thereof |
| 02/21/2002 | WO2001023558A3 Human secretory molecules |
| 02/21/2002 | WO2000066148A9 Novel proteins |
| 02/21/2002 | US20020023282 Methods for imparting desirable phenotypic traits, including drought, freeze, and high salt tolerance and methods for increasing seed production |
| 02/21/2002 | US20020023281 Expressed sequences of arabidopsis thaliana |
| 02/21/2002 | US20020023280 Expressed sequences of arabidopsis thaliana |
| 02/21/2002 | US20020023277 Vascular endothelial zinc finger 1 gene and protein and uses thereof |
| 02/21/2002 | US20020023276 Expression vectors for use in food processing; for use in the detction of cancer; for use in pre venting milk spoilage |
| 02/21/2002 | US20020022720 Anti-TNF antibodies and peptides of human tumor necrosis factor |
| 02/21/2002 | US20020022718 Genes identified as required for proliferation of E. coli |
| 02/21/2002 | US20020022715 Nervous system disorders; cardiovascular disorders; gastrointestinal disorders |
| 02/21/2002 | US20020022599 Methods of modulating drug clearance mechanisms by altering SXR activity |
| 02/21/2002 | US20020022595 Treating inflammation resulting from a response of the non-specific defense system in a mammal by administering an antiinflammatory agent and the uncontaminated Mac-1 alpha subunit |
| 02/21/2002 | US20020022592 Delivery of thrombospondin from implantable tissue matrices |
| 02/21/2002 | US20020022591 Polynucleotides and polypeptides comprising an ovarian tumor protein, antibodies directed against said polypeptides; diagnostic kits |
| 02/21/2002 | US20020022270 Human tissue cultures; inoculate vessel containing stromal tissue, continuously perfuse issue with nutrient broth, harvest preferential human tissue |
| 02/21/2002 | US20020022259 Cardiac-cell specific enhancer elements and uses thereof |
| 02/21/2002 | US20020022257 Three-dimensional structure and crystallization method of ribosome recycling factor (RRF) |
| 02/21/2002 | US20020022255 Expresson vectors; for use as tool in genetic engineering and gene therapy |
| 02/21/2002 | US20020022248 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 02/21/2002 | US20020022239 Fluorescent adducts comprising an apoprotein and a bilin (e.g. apophytochrome-phycoerythrobilin adducts); intensely fluorescent, photostable proteins useful as probes for biological research |
| 02/21/2002 | US20020022238 Genetically engineered microorganism for use as tools in the generation of heterologous binding proteins |
| 02/21/2002 | US20020022221 Organelle targeting protein; for use in treatment of viral disease |
| 02/21/2002 | US20020022035 Genetic engineering; deactivating toxin |
| 02/21/2002 | US20020022029 Human RRP sequences and methods of use |
| 02/21/2002 | US20020022028 Integrin antagonist; bone disorders |
| 02/21/2002 | US20020022027 Complexing to polypeptides; antiproliferation agent |
| 02/21/2002 | US20020022026 Osteoporosis |
| 02/21/2002 | US20020022025 Anticoagulants |
| 02/21/2002 | US20020022023 Treatment of diabetes mellitus and insulin receptor signal transduction |
| 02/21/2002 | US20020022021 Method of regulating transcription in a cell |
| 02/21/2002 | US20020022015 Administration system for seronegative of hepatitis C virus |
| 02/21/2002 | DE10127687A1 New DNA representing the Hero gene, for preparing transgenic plants resistant to Globodera cyst nematodes |
| 02/21/2002 | DE10110346A1 Neue für das IysR2-Gen kodierende Nukleotidsequenzen New coding for the IysR2 gene nucleotide sequences |
| 02/21/2002 | DE10109689A1 Neue für das metE-Gen kodierende Nukleotidsequenzen New coding for the metE gene nucleotide sequences |
| 02/21/2002 | DE10109686A1 Neue für das metf-Gen kodierende Nukleotidsequenzen New coding for the metF gene nucleotide sequences |
| 02/21/2002 | DE10039049A1 Novel polynucleotide from Coryneform bacteria coding for lysR3 gene, useful as a probe for detecting DNA to isolate nucleic acids coding for transcription regulator lysR3 or for producing L-amino acids, e.g., L-lysine and L-valine |
| 02/21/2002 | DE10039044A1 Novel polynucleotide from Coryneform bacteria coding for lysR1 gene, useful as hybridization probe for detecting DNA coding for transcription regulator lysR1 |
| 02/21/2002 | DE10039043A1 Neue für das luxR-Gen kodierende Nukleotidsequenzen New coding for the luxR gene nucleotide sequences |
| 02/21/2002 | DE10038382A1 Zweifarbiges fluorimetrisches Proteaseassay Two-toned fluorometric protease assay |
| 02/21/2002 | DE10036671A1 New nucleic acid encoding mitochondrial transporter, useful for preparing transgenic plants with e.g. altered protein content and improved germination |
| 02/21/2002 | DE10035292A1 Verfahren zur Gewinnung von Proteinen aus Pflanzen in reiner Form A process for the recovery of proteins from plant in pure form |
| 02/21/2002 | CA2804958A1 Therapeutic methods for treating subjects with a recombinant erythropoietin having high activity and reduced side effects |
| 02/21/2002 | CA2420037A1 Immunogenic hbc chimer particles having enhanced stability |
| 02/21/2002 | CA2419725A1 Genes involved in immune related responses observed with asthma |
| 02/21/2002 | CA2419545A1 .alpha.7 nicotinic receptor peptides as ligands for .beta. amyloid peptides |
| 02/21/2002 | CA2419533A1 Compositions and methods for the therapy and diagnosis of her-2/neu-associated malignancies |
| 02/21/2002 | CA2419503A1 Protein monitoring the activity of low-molecular weight gtp-binding protein |
| 02/21/2002 | CA2419491A1 Leucine-rich repeat-containing g-protein coupled receptor-8 molecules and uses thereof |
| 02/21/2002 | CA2419469A1 Derivatives of peptides and peptide mimetics having integrin inhibitor properties ii |
| 02/21/2002 | CA2419425A1 Novel diagnostic agents of chronic or persistent chlamydial diseases and uses thereof |
| 02/21/2002 | CA2419418A1 Vaccines containing ribavirin and methods of use thereof |
| 02/21/2002 | CA2419338A1 A method of producing biologically active human acidic fibroblast growth factor and its use in promoting angiogenesis |
| 02/21/2002 | CA2419245A1 Adeno-associated virus-mediated delivery of angiogenic factors |
| 02/21/2002 | CA2419203A1 Phage-dependent superproduction of biologically active protein and peptides |
| 02/21/2002 | CA2419182A1 Malaria immunogen and vaccine |
| 02/21/2002 | CA2419157A1 Improved insecticidal bacteria, and methods for making and using them |
| 02/21/2002 | CA2419133A1 Expression of herstatin, an alternative her-2/neu product, in cells that express either p185her-2 or the egf receptor inhibits receptor activity and cell growth |
| 02/21/2002 | CA2418725A1 Claudin polypeptides |
| 02/21/2002 | CA2418716A1 Integrin binding motif containing peptides and methods of treating skeletal diseases |
| 02/21/2002 | CA2418531A1 Therapeutic methods for treating subjects with a recombinant erythropoietin having high activity and reduced side effects |